All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Joseph Sabik, III, MD
Disclosure(s): Mectronic: Advisory Board (Ongoing), Speaker (Ongoing)

Joanna Chikwe, MD

Presentations

1. REvascularization CHoices Among Under-Represented Groups Evaluation (RECHARGE) Trial
   Mario FL Gaudino, MD, PhD, MSCE
   Disclosure(s): Abbott Vascular: Advisory Board (Terminated, May 12, 2023)
    
2. Moderated Panel Discussion and Audience Q&A: RECHARGE Trial
   Mario FL Gaudino, MD, PhD, MSCE
   Disclosure(s): Abbott Vascular: Advisory Board (Terminated, May 12, 2023)
   
   Michael Farkouh, MD, MSc
   Disclosure(s): Astra Zeneca: Advisory Board (Ongoing); Novo Nordisk: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Sanofi: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated)
   
   Michael Mack, MD
   Disclosure(s): Carmat: Corporate Board Member (Ongoing); Edwards Lifesciences: Trial Co-PI (Ongoing); Medtronic: Study Chair (Ongoing)
   
   Sigrid E. Sandner, MD